Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha)

Journal of Clinical Pharmacology

Volumn 43, Issue 6, 2003, Pages 637-642

  Tankanow, Roberta ^a   Tamer, Helen R ^a   Streetman, Daniel S ^a   Smith, Scott G ^a   Welton, Janice L ^a   Annesley, Thomas ^a   Aaronson, Keith D ^a   Bleske, Barry E ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Digoxin; Hawthorn; Heart failure; Pharmacokinetics

Indexed keywords

CRATAEGUS EXTRACT; DIGOXIN; FLAVONOID; GLYCOPROTEIN P;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG CROSS REACTIVITY; DRUG DOSAGE FORM; DRUG MECHANISM; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG SAFETY; FEMALE; FLATULENCE; FLOWER; FOLLOW UP; HEADACHE; HEART FAILURE; HEART PALPITATION; HERBAL MEDICINE; HUMAN; HUMAN EXPERIMENT; INSOMNIA; KIDNEY CLEARANCE; MALE; NAUSEA; NORMAL HUMAN; PLANT LEAF; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; VERTIGO;

EID: 0037566973     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/0091270003253417     Document Type: Article

References (23)

1. +-ATPase. Circulation 1997;96(Suppl.):4090.
2. Schussler M, Holzl J, Fricke W: Myocardial effects of flavonoids from Crataegus species. Arzneimittelforschung 1995;45:842-845.
3. Bahorun T, Gressier B, Trotin F, Brunet C, Dine T, Luyckx M, et al: Oxygen species scavenging activity of phenolic extracts from hawthorn fresh plant organs and pharmaceutical preparations. Arzneimittelforschung 1996;46:1086-1089.
4. Chen ZY, Zhang ZS, Kwan KY, Zhu M, Ho WKK, Huang Y: Endothelium-dependent relaxation induced by hawthorn extract in rat mesenteric artery. Life Sci 1998;63:1983-1991.
5. Kim SH, Kang KW, Kim KW, Kim ND: Procyanidins in Crataegus extract evoke endothelium-dependent vasorelaxation in rat aorta. Life Sci 2000;67:121-131.
6. Holubarsch CJF, Colucci WS, Meinertz T, Gaus W, Tendera M: Survival and prognosis: investigations of Crataegus extract WS 1442 in congestive heart failure (SPICE): rationale, study design, and study protocol. Eur J Heart Failure 2000;2:431-437.
7. Johne A, Brockmoller J, Bauer S, Agathe M, Langheinrich M, Roots I: Pharmacokinetic interaction of digoxin with an herbal extract from St. John's wort (Hypericum perforatum). Clin Pharmacol Ther 1999;66:338-345.
8. Critchfield JW, Welsh CJ, Phang JM, Yeh GC: Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Biochem Pharmacol 1994;48:1437-1445.
9. Conseil G, Cortay HB, Dayan G, Jault JM, Barron D, Di Pietro A: Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein. Proc Natl Acad Sci USA 1998;95:9831-9836.
10. Shapiro AB, Ling V: Effect of quercetin on hoechst 33342 transport by purified and reconstituted P-glycoprotein. Biochem Pharmacol 1997;53:587-596.
11. Phang JM, Poore CM, Lopaczynska J, Yeh GC: Flavonol-stimulated efflux of 7,12-dimethylbenz(a)anthracene in multidrug-resistant breast cancer cells. Cancer Res 1993;53:5977-5981.
12. Heart Failure Society of America: Guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction-pharmacological approaches. J Cardiac Failure 1999;5:357-382.
13. Nahrstedt A, Butterweck V: Biologically active and other chemical constituents of the herb of Hypericum perforatum L. Pharmacopsychiatry 1997;30(Suppl.):129-134.
14. Chang Q, Zhu M, Zuo Z, Chow M, Ho WK: High-performance liquid chromatographic method for simultaneous determination of hawthorn active components in rat plasma. J Chromatogr B Biomed Sci Appl 2001;760:227-235.
15. Zhang Z, Chang Q, Zhu M, Huang Y, Ho WK, Chen Z: Characterization of antioxidants present in hawthorn fruits. J Nutr Biochem 2001;12:144-152.
16. Obermeier MT, White RE, Yang CS: Effects of bioflavonoids on hepatic P450 activities. Xenobiotica 1995;25:575-584.
17. Scambia G, Ranelletti FO, Panici PB, De Vincenzo R, Bonanno G, Ferrandina G, et al: Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P- glycoprotein as a possible target. Cancer Chemother Pharmacol 1994;34:459-464.
18. Erlund I, Kosonen T, Alfthan G, Maenpaa J, Perttunen K, Kenraali J, et al: Pharmacokinetics of quercetin aglycone and rutin in healthy volunteers. Eur J Clin Pharmacol 2000;56:545-553.
19. Perloff MD, von Moltke LL, Stormer E, Shader RI, Greenblatt DJ: Saint John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposure. Br J Pharmacol 2001;134:1601-1608.
20. Greiner B, Eichelbaum M, Fritz P, Kreichgauer HP, von Richter O, Zundler J, et al: The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J Clin Invest 1999;104:147-153.
21. Lacarelle B, Rahmani R, de Sousa G, Durand A, Placidi M, Cano JP: Metabolism of digoxin, digoxigenin digitoxosides and digoxigenin in human hepatocytes and liver microsomes. Fundam Clin Pharmacol 1991;5:567-582.
22. Schussler M, Holzl J, Rump AFE, Fricke U: Functional and antiischemic effects of monoacetyl-vitexinrhamnoside in different in vitro models. Gen Pharmacol 1995;26:1565-1570.
23. Rigelsky JM, Sweet BV: Hawthorn: pharmacology and therapeutic uses. Am J Health-Syst Pharm 2002;59:417-422.